| 2.1.21.04. |
Matrix protein p19 |
1a6s |
Rous sarcoma virus |
1 |
0 |
3.1 ± 2.7 |
89 ± 14 |
-3.6 |
| 2.1.21.01. |
Influenza virus matrix protein M1 |
1aa7 |
Influenza virus |
2 |
0 |
2.6 ± 0.8 |
89 ± 4 |
-5.6 |
| 3.1.07.02. |
Envelope glycoprotein gp41 |
1df4 |
Human immunodeficiency virus type 1 |
3 |
0 |
6.3 ± 0.9 |
0 ± 10 |
-6.7 |
| 3.1.07.04. |
Envelope glycoprotein E1, heterodimerization peptide (350-370) |
1emz |
Hepatitis C virus |
1 |
0 |
6.2 ± 0.2 |
86 ± 9 |
-8.5 |
| 3.1.07.03. |
Hemagglutinin, fusion peptide 346-365, conformation 1 |
1ibn |
Influenza virus |
1 |
0 |
9.1 ± 1.2 |
67 ± 7 |
-8.0 |
| 2.4.50.01. |
Matrix protein |
1lg7 |
Vesicular stomatitis virus |
1 |
0 |
2.7 ± 0.4 |
82 ± 2 |
-7.3 |
| 2.2.19.01. |
Adsorption protein p2 |
1n7v |
Bacteriophage prd1 |
1 |
0 |
8.7 ± 0.4 |
81 ± 1 |
-8.6 |
| 1.2.43.01. |
Major envelope glycoprotein E, ectodomain |
1ok8 |
Dengue virus |
3 |
0 |
5.2 ± 0.9 |
0 ± 6 |
-9.5 |
| 1.2.43.02. |
Fusion glycoprotein E1 |
1rer |
Semiliki forest virus |
3 |
0 |
2.6 ± 2.0 |
38 ± 5 |
-6.5 |
| 3.1.07.02. |
Paramyxovirus sv5 fusion protein core |
1svf |
Simian virus 5 |
6 |
0 |
8.4 ± 0.9 |
0 ± 11 |
-10.7 |
| 1.2.43.01. |
Envelope glycoprotein |
1urz |
Tick-borne encephalitis virus |
3 |
0 |
5.9 ± 0.9 |
1 ± 8 |
-10.3 |
| 3.1.07.03. |
Hemagglutinin, fusion peptide 346-365, different strain |
1xop |
Influenza virus |
1 |
0 |
6.3 ± 0.5 |
70 ± 13 |
-11.0 |
| 1.2.43.04. |
Glycoprotein G |
2cmz |
Vesicular stomatitis virus |
3 |
0 |
6.6 ± 0.0 |
3 ± 0 |
-10.5 |
| 1.2.11.02. |
Capsid protein G8P |
2cps |
Bacteriophage M13 |
1 |
1 |
30.8 ± 3.1 |
15 ± 3 |
-19.9 |
| 2.1.21.02. |
Matrix protein p10 |
2f76 |
Mason-Pfizer monkey virus |
1 |
0 |
3.9 ± 1.2 |
48 ± 5 |
-5.8 |
| 1.2.43.06. |
Spike glycoprotein |
2ghv |
Human SARS coronavirus |
1 |
0 |
3.8 ± 1.9 |
45 ± 9 |
-6.8 |
| 3.1.07.03. |
Hemagglutinin, peptide 330-349 |
2jrd |
Influenza virus |
1 |
0 |
8.1 ± 4.0 |
71 ± 5 |
-6.8 |
| 1.2.23.01. |
M2 proton channel of Influenza B |
2kix |
Influenza virus |
4 |
4 |
31.8 ± 1.2 |
2 ± 3 |
-64.4 |
| 1.2.23.01. |
M2 proton channel of Influenza A, complex with amantadine |
2kqt |
Influenza virus |
4 |
4 |
30.2 ± 1.3 |
0 ± 4 |
-59.6 |
| 1.2.23.01. |
M2 proton channel of Influenza A, closed state, V27A mutant |
2kwx |
Influenza virus |
4 |
4 |
33.4 ± 1.9 |
2 ± 3 |
-63.4 |
| 3.1.07.03. |
Hemagglutinin, fusion peptide 346-365, conformation 3 |
2kxa |
Influenza virus |
1 |
0 |
10.3 ± 1.9 |
84 ± 13 |
-14.5 |
| 3.1.07.03. |
Hemagglutinin, fusion peptide 346-365, conformation 2 |
2l4g |
Influenza virus |
1 |
0 |
11.1 ± 0.4 |
73 ± 4 |
-10.4 |
| 3.1.01.03. |
Viral core-E1 signal peptide |
2lif |
Hepatitis C virus |
1 |
1 |
29.6 ± 5.0 |
19 ± 10 |
-16.6 |
| 1.2.23.01. |
M2 proton channel, influenza A and B hydrid |
2ljb |
Influenza virus |
4 |
4 |
31.6 ± 1.6 |
1 ± 1 |
-51.3 |
| 1.2.23.01. |
M2 proton channel, influenza A and B hydrid, complex with rimantadine |
2ljc |
Influenza virus |
4 |
4 |
30.6 ± 1.8 |
9 ± 2 |
-44.9 |
| 3.1.07.02. |
gp41-M-MAT, a membrane associated MPER trimer |
2lp7 |
Human immunodeficiency virus type 1 |
3 |
3 |
26.8 ± 0.9 |
1 ± 1 |
-14.2 |
| 2.1.21.02. |
Matrix protein p10, myristoylated |
2lpy |
Mason-Pfizer monkey virus |
1 |
0 |
3.2 ± 0.5 |
8 ± 6 |
-3.4 |
| 1.2.23.01. |
M2 proton channel of Influenza A, closed state, S31N, with drug |
2ly0 |
Influenza virus |
4 |
4 |
34.0 ± 1.6 |
0 ± 0 |
-67.5 |
| 1.2.23.01. |
M2 proton channel of Influenza A, closed state, NMR |
2rlf |
Influenza virus |
4 |
4 |
34.3 ± 2.0 |
3 ± 1 |
-67.6 |
| 2.4.50.01. |
Matrix protein, different conformation |
2w2r |
Vesicular stomatitis virus |
1 |
0 |
4.1 ± 0.1 |
57 ± 1 |
-10.4 |
| 3.1.07.02. |
Envelope glycoprotein gp41 |
2x7r |
Human immunodeficiency virus type 1 |
3 |
0 |
5.5 ± 1.1 |
0 ± 10 |
-10.9 |
| 1.2.43.01. |
E1/E2 envelope glycoprotein complex |
2yew |
Barmah forest virus |
8 |
8 |
30.0 ± 0.8 |
0 ± 0 |
-53.5 |
| 1.2.23.01. |
M2 proton channel of Influenza A, open state, ligand-free |
3bkd |
Influenza virus |
4 |
4 |
27.1 ± 1.8 |
3 ± 1 |
-55.0 |
| 1.2.23.01. |
M2 proton channel of Influenza A, open state, complex with amantadine |
3c9j |
Influenza virus |
4 |
4 |
29.4 ± 1.4 |
2 ± 3 |
-65.6 |
| 1.2.43.05. |
Major envelope glycoprotein |
3duz |
Autographa californica nuclear polyhedrosis virus |
3 |
0 |
3.2 ± 0.4 |
4 ± 6 |
-9.3 |
| 1.2.43.01. |
Envelope protein |
3g7t |
Dengue virus |
3 |
0 |
5.9 ± 0.9 |
1 ± 3 |
-12.2 |
| 1.2.43.01. |
Capsid envelop protein complex |
3j2p |
Dengue virus |
4 |
8 |
22.8 ± 0.4 |
0 ± 0 |
-62.7 |
| 1.2.43.01. |
E1/E2 envelope glycoprotein complex |
3j2w |
Chikungunya virus |
8 |
8 |
30.8 ± 0.9 |
2 ± 0 |
-134.1 |
| 1.2.23.01. |
M2 proton channel of Influenza A, closed state |
3lbw |
Influenza virus |
4 |
4 |
31.1 ± 1.7 |
7 ± 10 |
-50.5 |
| 1.2.43.03. |
Envelope glycoprotein B |
3nw8 |
Human herpesvirus |
3 |
0 |
4.6 ± 0.0 |
1 ± 1 |
-11.7 |
